Nipah@20: Lessons Learned from Another Virus with Pandemic Potential
Raúl Gómez Román,
Lin-Fa Wang,
Benhur Lee,
Kim Halpin,
Emmie de Wit,
Christopher C. Broder,
Mahmudur Rahman,
Paul Kristiansen,
Melanie Saville
Affiliations
Raúl Gómez Román
Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway
Lin-Fa Wang
Duke-NUS Medical School, Singapore
Benhur Lee
Icahn School of Medicine at Mount Sinai, New York, New York, USA
Kim Halpin
Australian Centre for Disease Preparedness (ACDP), Geelong, Australia
Emmie de Wit
Laboratory of Virology, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health, Hamilton, Montana, USA
Christopher C. Broder
Department of Microbiology and Immunology, Uniformed Services University, Bethesda, Maryland, USA
Mahmudur Rahman
Independent Consultant, Dhaka, Bangladesh
Paul Kristiansen
Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway
Melanie Saville
Coalition for Epidemic Preparedness and Innovations (CEPI), Oslo, Norway
ABSTRACT Nipah disease is listed as one of the WHO priority diseases that pose the greatest public health risk due to their epidemic potential. More than 200 experts from around the world convened in Singapore last year to mark the 20th anniversary of the first Nipah virus outbreaks in Malaysia and Singapore. Most of these experts are now involved in responding to the coronavirus disease 2019 (COVID-19) pandemic. Here, members of the Organizing Committee of the 2019 Nipah Virus International Conference review highlights from the Nipah@20 Conference and reflect on key lessons learned from Nipah that could be applied to the understanding of the COVID-19 pandemic and to preparedness against future emerging infectious diseases (EIDs) of pandemic potential.
